Receiving a heart transplant is a life-changing journey, and you may be wondering about your treatment options. This is why The Heart Hub is excited to introduce A Hearts Journey: A Patient & Caregiver Guide to Heart Transplant. This brand-new, interactive...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
A national entrepreneurship training program designed to bridge the translational gap for cardiovascular innovations.
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a specialized experiential training program led by veteran entrepreneurs and consultants across a variety of sectors. ECHO provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking, and funding opportunities.
Ventures accepted into ECHO are required to:
Any Canadian-based clinician, researcher, student and/or entrepreneur developing advanced cardiovascular technologies and innovations is eligible to apply. This is an ideal opportunity for researchers, postdoctoral fellows, clinical trainees and graduate students who are self-starters and want to refine their career path in a knowledge-based economy while working in an innovation-based environment.
Founded in 2018, ECHO is a 12-month online training program with the main objectives to:
ECHO is led by high-calibre academic, industry and government subject matter experts, and it is comprised of a unique combination of five complementary modules.
Our program is funded and organized in a partnership between:
For more information, contact ECHO co-founder Soror Sharifpoor, also director of strategy and translation for the Centre’s Translational Biology and Engineering Program.
The MaRS Entrepreneur’s Toolkit Workshops are a collection of experiential and hands-on workshops that are facilitated by veteran entrepreneurs. It targets fundamental entrepreneurship principles such as value proposition, business models, finance fundamentals, marketing and communication, and pitching to investors.
A series of interactive workshops focused on key subjects pivotal to the success of early stage start-ups in the health sector such as market research, corporate governance, intellectual property, regulatory strategy, clinical trials, quality systems, health technology assessment, procurement, funding and government resources, and investments, and partnerships.
They are facilitated by academic, industry and government subject matter experts.
A webinar series in which successful entrepreneurs and business leaders share their experiences in commercializing technologies in the cardiovascular health sector.
Guest speakers include executives and founders of medical device, biotechnology and digital health companies.
Successfully ranked ventures will become clients of the Health Innovation Hub (H2i) with access to: (1) H2i’s extensive network of industry, government and academic advisors; (2) peer-to-peer mentorship by start-up mentors selected from H2i’s venture portfolio; (3) professional funding; and (4) H2i events (e.g. Accelera program).
The program will culminate with pitch training, private pitch sessions and ECHO PITCH 2025: a public competition event, where the program ventures will have the opportunity to win start-up funding from a $250,000 pool. There will also be opportunities for follow-on funding via our partners.
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a specialized training program led by veteran entrepreneurs and consultants across a variety of sectors.
No, you do not need to be a Canadian citizen or permanent resident to apply for ECHO. The only requirement is that your cardiovascular technology/innovation is being developed in a Canadian institution/company.
No, you do not need to have formed a start-up company around your technology. However, you must be developing a cardiovascular technology/innovation that you intend to commercialize.
ECHO is a 12-month program starting from October 2024. Its workshops, webinars and Accelera sessions are held weekdays during typical work hours and are scheduled as follows:
Module 1 workshops: October – December 2024
During this period, 9 workshops (2 hours/session) will take place from October to December 2024. Each week will include one 2-hour workshop. The workshops will be held on Tuesdays at 10 am – 12 pm ET.
Module 2 workshops, Module 3 webinars and Module 4 Accelera sessions: January – June 2025
Module 2 workshops (2 hours/session), Module 3 webinars (1 hour/session), and Module 4 Accelera sessions (1 hour/session) will be held during this 6-month period with one session held weekly. All sessions will be held on Tuesdays in the 10 am – 12 pm ET timeslot.
Module 5: Pitch development: July – September 2025
During this summer stretch, there will be no workshops, webinars or Accelera sessions. Instead, ECHO ventures will have the opportunity to perfect their pitch deck, compete in a first-round pitch competition and receive pitch training, speaker coaching and mentorship on their go-to-market strategy.
Final pitch competition: October 2025
The program culminates in a final pitch competition (ECHO PITCH), which will be held in October 2024, where select ECHO ventures will have the opportunity to compete for start-up funding.
More details on the schedule will be provided in fall 2024.
Yes: all workshops, webinars, mentorship sessions and meetings are held online. At least one member of each selected venture must participate.
In order to be eligible to compete in the final pitch competition for the opportunity to win start-up funding, at least one member of your venture must attend a minimum of 80% of all program workshops and webinars.
There are no costs associated with ECHO. ECHO is a free entrepreneurial training program for ventures that are successfully accepted into the program.
Yes, ECHO is strategically scheduled to build a strong entrepreneurial knowledge base for its participants. Thus, all modules have to be completed within the scheduled period.
Yes, ECHO is funded and organized through two U of T programs: (i) the Translational Biology and Engineering Program, which is the U of T component of the Ted Rogers Centre for Heart Research; and (ii) the Health Innovation Hub (H2i), a campus-linked accelerator.
At this time there is no formal certification associated with ECHO.